FSRH, RCOG, RCGP and BMS statement: access to Hormone Replacement Therapy during COVID-19 outbreak  

Posted 27 March 2020

Date: 27 Mar 2020

Type: FSRH Press Releases and Statements

We recognise that many women are likely to experience difficulties in obtaining HRT supplies due to the current coronavirus situation. We also appreciate that continuing HRT intake is likely to help many women control their often difficult menopausal symptoms, which is particularly relevant given the additional stress some women may be under in view of the strains of the current situation on society.

Furthermore, General Practitioners’ surgeries have also been put under additional pressure, with consultations and advice prioritised to dealing with serious and potentially life-threatening medical issues. 

Recognising the current constraints, we recommend that General Practitioners and healthcare providers consider advising women about menopause issues through telephone and virtual consultations where at all possible to reduce face to face engagement, and with easy access to repeat prescriptions of HRT supplies (especially to women who have been on HRT and have not been experiencing any problems with their intake). This will help to avoid the need for many women to visit their GP surgery to discuss these issues and assist with obtaining repeat prescriptions. 


Haitham Hamoda | Chairman, BMS

Edward Morris | President, RCOG

Martin Marshall | Chair, RCGP 

Asha Kasliwal | President, FSRH